A. Nattermann & Cie Gmbh

Josef P Lohr

Gerd Hilboll

Hans-Heiner Lautenschlager

Hugo Friehe

Gerrit Prop

Ille-Stephanie Doppelfeld

Harald O Borbe

The invention relates to new imidazolylalkylthienyltetrahydropyridazines of the general formula I ##STR1## their acid addition salts as well as processes for their use in the treatment of cardiovascular and/or thromboembolic illnesses in humans.

Imidazolylalkylthienyl tetrahydropyridazines and processes for their use

The invention relates to new 6-{4-(.omega.-(1-imidazolyl)-alkyl)-phenyl}-3-oxo-2,3,4,5-tetrahydro-pyrid azines having the general formula I ##STR1## and acid addition salts thereof, and to a process for the treatment of inflammatory, atherosclerotic and thromboembolic diseases especially in humans.

6-{4-(.omega.-(1-imidazolyl)-alkyl-phenyl}-3-oxo-2,3,4,5-tetrahydro-

The invention relates to new 6-{5-[.omega.-(1-imidazolyl)-alkyl]-thien-2-yl}-3-oxo-2,3,4,5-tetrahydro-p yridazines having the general formula I ##STR1## and acid addition salts thereof and to a process for the treatment of inflammatory, atherosclerotic and thrombo-embolic diseases especially in humans.

Growing community of inventors

Hilden, Germany

Josef P Lohr